Page last updated: 2024-08-21

dronabinol and Peripheral Nervous System Diseases

dronabinol has been researched along with Peripheral Nervous System Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D	1
Ehler, E; Hovorka, J; Lauder, H; Ratcliffe, S; Schofield, M; Serpell, M; Taylor, L	1
Smith, PF	1
Wallace, JM	1
Haines, D; Hoggart, B; Morlion, BJ; Nurmikko, TJ; Serpell, MG; Toomey, PJ	1

Reviews

2 review(s) available for dronabinol and Peripheral Nervous System Diseases

Article	Year
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. Journal of medicinal chemistry, 2010, Jul-22, Volume: 53, Issue:14 Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels	2010
Update on pharmacotherapy guidelines for treatment of neuropathic pain. Current pain and headache reports, 2007, Volume: 11, Issue:3 Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes	2007

Article

Year

Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.

Journal of medicinal chemistry, 2010, Jul-22, Volume: 53, Issue:14

Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels

2010

Update on pharmacotherapy guidelines for treatment of neuropathic pain.

Current pain and headache reports, 2007, Volume: 11, Issue:3

Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes

2007

Trials

2 trial(s) available for dronabinol and Peripheral Nervous System Diseases

Article	Year
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. European journal of pain (London, England), 2014, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome	2014
Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain, 2007, Dec-15, Volume: 133, Issue:1-3 Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Hyperesthesia; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Plant Extracts; Psychomotor Performance; Time Factors; Treatment Outcome	2007

Article

Year

A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.

European journal of pain (London, England), 2014, Volume: 18, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome

2014

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.

Pain, 2007, Dec-15, Volume: 133, Issue:1-3

Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Hyperesthesia; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Plant Extracts; Psychomotor Performance; Time Factors; Treatment Outcome

2007

Other Studies

1 other study(ies) available for dronabinol and Peripheral Nervous System Diseases

Article	Year
GW-1000. GW Pharmaceuticals. Current opinion in investigational drugs (London, England : 2000), 2004, Volume: 5, Issue:7 Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Canada; Cannabidiol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dronabinol; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Humans; Hyperalgesia; Investigational New Drug Application; Mice; Molecular Structure; Multiple Sclerosis; Patents as Topic; Peripheral Nervous System Diseases; Phytotherapy; Plant Extracts; Plant Preparations; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Structure-Activity Relationship	2004

Article

Year

GW-1000. GW Pharmaceuticals.

Current opinion in investigational drugs (London, England : 2000), 2004, Volume: 5, Issue:7

Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Canada; Cannabidiol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dronabinol; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Humans; Hyperalgesia; Investigational New Drug Application; Mice; Molecular Structure; Multiple Sclerosis; Patents as Topic; Peripheral Nervous System Diseases; Phytotherapy; Plant Extracts; Plant Preparations; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Structure-Activity Relationship

2004